20 Bilder zum Thema "programmed death" bei ClipDealer

Medien sortieren nach     Gehe zu Seite:    
« Vorherige  1  Nächste »
Immune checkpoint inhibitors in cancer treatment, 3D illustration. Inhibitors of PD-1 receptor and PD-L1 prevent the tumour cell from binding to PD-1 and enable the T cell to remain active
Immune checkpoint inhibitors in cancer treatment, 3D illustration. Inhibitors of PD-1 receptor and PD-L1 prevent the tumour cell from binding to PD-1 and enable the T cell to remain active
Apoptosis
Cell infected with virus particles causing cell death- 3d illustration
Cell infected with virus particles causing cell death- 3d illustration
Apoptosis
Interactions of MHC-II with the T-cell receptor and CD4 and B7-1 with CD-28 activates T-cells while the interactions of P7-1 with CTLA-4 and PD-L1 with PD-1 deactivates T-cells.
PD-1 (red) extends from the surface of a T-cell and interacts with the ligand protein PD-L1 (yellow) from a antigen presenting cell. Although the T-cell has been activated through the interaction of a T-cell receptor (blue) and a MHC protein (viole
Cancer cells express PD-L1 (orange) proteins on their surface to trick the immune system. The interaction of PD-L1 with PD-1 of T-cells leads to a down-regulation of T-cells. The antibody (yellow) blocks this interaction.
Cell infected with virus particles causing cell death- 3d illustration
Interaction of MHC-II (red) with the T-cell receptor (blue) and CD4 (light blue) and B7-1 (orange) with CD-28 (dark blue) activates T-cells while the interaction of P7-1 with CTLA-4 (violett) and PD-L1 (yellow) with PD-1 deactivates T-cells
Cardiac pacemaker
Necrosis background concept
Molecular model of Pembrolizumab, a humanized antibody used in immunotherapy of cancer, 3D illustration. It targets the PD-1 receptor of lymphocytes
Immunologically active proteins on a T-cell. TCR (blue), CD-4 (light blue), CD-28 (dark blue), PD-1 (magenta), CTLA-4 (violet), Ca-channel (dark violet). The T-cell receptor, CD-4 and CD-28 activate T-cells, while PD-1 and CTLA-4 inhibit the activat
Molecular model of Pembrolizumab, a humanized antibody used in immunotherapy of cancer, 3D illustration. It targets the PD-1 receptor of lymphocytes
Molecular model of Pembrolizumab, a humanized antibody used in immunotherapy of cancer, 3D illustration. It targets the PD-1 receptor of lymphocytes
Types of Necrosis (death of body tissue) mind map text concept for presentations and reports
Types of Necrosis (death of body tissue) mind map text concept for presentations and reports
Types of Necrosis (death of body tissue) mind map text concept for presentations and reports

« Vorherige  1  Nächste »